Spatial profiling of solid tumor microenvironment using imaging mass cytometry with high-plex panels.

T Thomas Daniel Pfister (Standard BioTools, Markham, ON, Canada) J Jyh Yun Chwee (Standard BioTools, Markham, ON, Canada) N Nick Zabinyakov (Standard BioTools) Q Qanber Raza (Standard BioTools) D David Howell (Standard BioTools, Toronto, ON, Canada) L Liang Lim (Standard BioTools) C Christina Loh (Standard BioTools)

Abstract

e14574 Background: Understanding cellular interactions within the tumor microenvironment (TME) is essential for elucidating disease progression and advancing immunotherapy. The TME is a complex ecosystem composed of cells with dysregulated metabolism immune response and signaling pathways, which in turn influence tumor development and treatment response. Multiplexed assessment serves as an important tool for clinical oncology. The simultaneous readout of multiple processes can provide biological insights and elucidate disease mechanism. Imaging Mass Cytometry (IMC) is a spatial biology imaging technique that utilizes CyTOF technology and enables deep characterization of the diversity and complexity of the TME. IMC technology offers scalable, high-throughput acquisition while generating high-quality data with true dynamic range of signal without amplification or fluorescence-based limitations such as spectral overlap and autofluorescence. Methods: To study cellular processes and their roles in tumor progression, we utilized the Human Cell Metabolism and Human Cell Signaling Panels to investigate energy production, cellular homeostasis and mitogenic signaling pathways. We then mapped these processes to the types of cells in the TME by using the Human Immuno-Oncology IMC Panel and the Human T Cell Exhaustion IMC Panel or the Maxpar Neuro Phenotyping IMC Panel Kit to characterize immune cell and neurological phenotypes in detail. We first acquired data using Preview Mode to assess the whole tissue, followed by higher-resolution imaging of selected regions of interest using Cell Mode or of the whole tissue section using Tissue Mode. Results: Our data analysis revealed significant insights into the spatial organization and metabolic profile of cells across cancer tissues. Elevated glycolysis and mTOR pathway activation suggested adaptations to hypoxia and anabolic growth in tumor areas, while interactions between fibroblasts and immune cells highlighted crosstalk within the TME. Our Neuro Phenotyping Panel was used to reveal potential for immune response in glioblastoma. Unsupervised pixel clustering and hierarchical clustering using MCD SmartViewer highlighted metabolic activity and activation of signaling pathways within tumor regions. Conclusions: Comprehensive spatial biology profiling using the IMC approach highlights the interconnected roles these pathways play in promoting tumor survival and resistance to therapies. These findings, which illuminate the metabolic and signaling heterogeneity of the TME, are crucial for developing future prognostic assessments and have the potential to guide more effective, personalized cancer therapies. For Research Use Only. Not for use in diagnostic procedures.

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (7)

T

Thomas Daniel Pfister

Standard BioTools, Markham, ON, Canada

J

Jyh Yun Chwee

Standard BioTools, Markham, ON, Canada

N

Nick Zabinyakov

Standard BioTools

Q

Qanber Raza

Standard BioTools

D

David Howell

Standard BioTools, Toronto, ON, Canada

L

Liang Lim

Standard BioTools

C

Christina Loh

Standard BioTools